Neuronetics Correlations
STIM Stock | USD 1.00 0.04 4.17% |
The current 90-days correlation between Neuronetics and Burning Rock Biotech is 0.15 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neuronetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neuronetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Neuronetics Correlation With Market
Modest diversification
The correlation between Neuronetics and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neuronetics and DJI in the same portfolio, assuming nothing else is changed.
Neuronetics |
Moving against Neuronetics Stock
0.5 | CI | Cigna Corp | PairCorr |
0.59 | IRIX | IRIDEX | PairCorr |
0.31 | FNA | Paragon 28 | PairCorr |
0.35 | ALGN | Align Technology | PairCorr |
0.35 | SRDX | SurModics | PairCorr |
0.35 | TNDM | Tandem Diabetes Care | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Neuronetics Stock performing well and Neuronetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neuronetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BNR | 5.57 | 0.29 | 0.05 | 0.28 | 7.80 | 16.01 | 46.14 | |||
DRIO | 4.10 | (0.17) | (0.01) | 0.04 | 4.60 | 9.72 | 27.55 | |||
GTH | 1.87 | 0.00 | (0.03) | 0.13 | 2.49 | 3.45 | 14.43 | |||
SERA | 3.74 | (0.22) | 0.00 | 0.04 | 4.58 | 9.55 | 27.67 | |||
BDSX | 2.61 | (0.28) | 0.00 | 4.87 | 0.00 | 5.95 | 29.48 | |||
FONR | 1.50 | (0.15) | 0.00 | (0.09) | 0.00 | 2.15 | 10.84 | |||
ENZ | 1.40 | (0.01) | (0.06) | 0.09 | 1.31 | 2.97 | 7.62 | |||
XGN | 3.75 | 0.47 | 0.13 | 0.60 | 3.40 | 9.62 | 25.65 | |||
SHC | 1.75 | (0.37) | 0.00 | (0.14) | 0.00 | 3.74 | 13.40 | |||
OLK | 0.63 | 0.19 | 0.05 | (0.80) | 0.48 | 1.58 | 4.37 |
Neuronetics Corporate Management
Rusty Page | Senior Quality | Profile | |
Lisa MetznerRosas | Senior Officer | Profile | |
Andrew Macan | Gen VP | Profile | |
Claire Sears | VP Marketing | Profile | |
Rick Grubbs | Senior Accounts | Profile | |
Cory Anderson | Senior Clinical | Profile | |
Kara Thornton | VP Director | Profile |